Market Intelligence Center  Oct 30  Comment 
After closing Wednesday at $52.18, Align Technology Inc (ALGN) presents an attractive opportunity to get a 2.29% return in just 51 days, which is an annualized return of 16.40% (for comparison purposes only). To enter this trade, sell one Dec. '14...
Motley Fool  Oct 23  Comment 
A look behind the numbers from Align Technology's solid Q3 results.
Motley Fool  Oct 21  Comment 
Should investors brace for good news or bad news from Align Technology's Q3 results?
StreetInsider.com  Oct 20  Comment 
The following is a list of notable articles to help get you through the lunch hour: Recent Investor Exodus from Western Digital (WDC) Might Create Buying Opportunity - Barron's -> Read this! SunEdison (SUNE) Gains; Hearing Einhorn Recommended...
Benzinga  Oct 20  Comment 
Credit Suisse upgraded Align Technology, Inc. (NASDAQ: ALGN) from Neutral to Outperform with a $58 price target. Analyst Glen Santangelo noted that "following significant outperformance in 2013, shares of ALGN have lagged the broader market...
Forbes  Oct 9  Comment 
Investors eyeing a purchase of Align Technology Inc (NASD: ALGN) stock, but tentative about paying the going market price of $47.60/share, might benefit from considering selling puts among the alternative strategies at their disposal. One...
Market Intelligence Center  Oct 7  Comment 
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with Align Technology Inc (ALGN) that should provide a 7.40% return in just 102 days. Sell one Jan. '15 call at the $47.00 level for each 100...
DailyFinance  Sep 25  Comment 
SAN JOSE, CA -- (Marketwired) -- 09/25/14 -- Align Technology, Inc. (NASDAQ: ALGN) today expanded digital workflow options for the iTero® Intraoral Scanner by announcing availability of DENTSPLY Implants digital workflow that features...


Related Articles


Align Technology, Inc., founded in 1997, is engaged in the design, manufacture, and marketing of Invisalign, a proprietary system for treating malocclusion, or crooked teeth. The Invisalign product has two components, ClinCheck and Aligners. ClinCheck is an Internet-based application that allows dental professionals to simulate treatment in three dimensions, by modeling two-week stages of tooth movement. Aligners are thin, clear-plastic, removable dental appliances that are manufactured in a series to correspond to each two-week stage of the ClinCheck simulation. Aligners are customized to perform the treatment prescribed for an individual patient by dental professionals using ClinCheck. Invisalign is approved to treat patients, with any type of malocclusion, with mature upper and lower tooth structures. The company voluntarily restricts the use of Invisalign to adults and adolescents with immature structures. Typically, permanent structures occur in the later-teen years. Align does not treat children whose teeth and jaws are still developing, as the effectiveness of Invisalign relies on the company's ability to accurately predict the movement of teeth over the course of treatment. Based on its clinical studies to date, Align recommends that dental professionals use Invisalign as a complete treatment for a range of malocclusions, and as a component of treatment for severe malocclusions.

Internationally, the company operates in the regions of Europe, Asia/Pacific, and Latin America. At the end of 2007, sales in the domestic orthodontist channel represented 30% of total revenues, while sales in the domestic general practitioner (GP) channel represented 46%, and the international channel represented 20%. The remaining 5% came from education training and other revenues.


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki